Brief: US Food And Drug Administration Grants Regulatory Clearance To IceCure For Next-Gen XSense Cryoablation System With CryoProbes
01/07/2024 14:57
July 1 (Reuters) - Icecure Medical Ltd ICCM.O :
* U.S. FOOD AND DRUG ADMINISTRATION GRANTS REGULATORY
CLEARANCE TO
ICECURE FOR NEXT-GEN XSENSE™ CRYOABLATION SYSTEM WITH CRYOPROBES
Source text for Eikon: ID:nPn4bRkq4a
Further company coverage: ICCM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Icecure Medical
See all newsIcecure Medical Ltd reports results for the quarter ended June 30 - Earnings Summary
Israel's IceCure Medical H1 revenue rises on higher system, probe sales
Brief: Icecure Sio Petitions Nccn To Include Cryoablation In Breast Cancer Treatment Guidelines, Citing Icecure's FDA Clearance Of Prosense®
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:45 AM